GSK has spent slightly more on lobbying this year compared with 2023. The company spent $3.87 million in the first three ...

Kennedy Jr. has his way, get ready for even more anti-pharma rhetoric and potential instability at the Food and Drug ...

GSK’s departure comes as the industry anticipates the incoming Trump administration and as it continues to grapple with the threat of the BIOSECURE Act and losses of legal challenges to the IRA’s drug ...

The Indian pharmaceutical market (IPM) registered a 6.1 per cent value growth in October 2024, with major therapies showing ...

GSK confirmed this morning that the disappointing ... that covers branded medicines pricing and access. The AI effect in pharma commercial strategy: From data to re... Discover how AI is ...

The NYT Mini is a quick and dirty version of the newspaper's larger and long-running crossword. Most days, there are between ...

The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms, ...